Opioid receptor-activation: Retina protected from ischemic injury

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 8, 2009, Pages 3853-3859

  Husain, Shahid ^a   Potter, David E ^a   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRORETINOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MALE; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA ISCHEMIA; RISK REDUCTION; WESTERN BLOTTING; ANIMAL; BROWN NORWAY RAT; DRUG EFFECT; METABOLISM; PATHOLOGY; REPERFUSION INJURY; RETINA BLOOD VESSEL; RETINA DEGENERATION;

ANIMALS; BLOTTING, WESTERN; ELECTRORETINOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, INBRED BN; RECEPTORS, OPIOID; REPERFUSION INJURY; RETINAL DEGENERATION; RETINAL VESSELS;

EID: 68349091472     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2907     Document Type: Article

References (45)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91-147.
2. Whitlock NA, Agarwal N, Ma JX, Crosson CE. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2005;46:1092-1098.
3. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998;39: 777-785.
4. Centurion SA, Centurion LM, Souza ME, et al. Effects of ischemic liver preconditioning on hepatic ischemia/reperfusion injury in the rat. Transplant Proc. 2007;39:361-364.
5. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221-224.
6. Kato H, Araki T, Murase K, Kogure K. Induction of tolerance to ischemia: alterations in second-messenger systems in the gerbil hippocampus. Brain Res Bull. 1992;29:559-565.
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
8. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89:123-137.
9. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA. 1992;89: 12048-12052.
10. Simonin F, Gaveriaux-Ruff C, Befort K, et al. kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci USA. 1995; 92: 7006-7010.
11. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor: cDNA and genomic clones, pharma-cologic characterization and chromosomal assignment. FEBS Lett. 1994;338:217-222.
12. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci. 1984;7:223-255.
13. Maslov LN, Lishmanov YB. Change in opioid peptide level in the heart and blood plasma during acute myocardial ischaemia complicated by ventricular fibrillation. Clin Exp Pharmacol Physiol. 1995;22:812-816.
14. Paradis P, Dumont M, Belichard P, Rouleau JL, Lemaire S, Brakier-Gingras L. Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction. Biochem Cell Biol. 1992;70:593-598.
15. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vasc Pharmacol. 2005; 42:211-218.
16. Rubaj A, Gustaw K, Zgodzinski W, Kleinrok Z, Sieklucka-Dziuba M. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol Biochem Behav. 2000;67:65-70.
17. Chien GL, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol. 1996;28:1895-1900.
18. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995;268:H2157-H2161.
19. Ferri S, Speroni E, Candeletti S, et al. Protection by opioids against gastric lesions caused by necrotizing agents. Pharmacology. 1988; 36:140-144.
20. Mayfield KP, D'Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther. 1994;268:683-688.
21. Arrigo-Reina R, Ferri S. Evidence of an involvement of the opioid peptidergic system in the reaction to stressful conditions. Eur J Pharmacol. 1980;64:85-88.
22. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reper-fusion in intact rat hearts. Circ Res. 2004;94:960-966.
23. Chen TY, Goyagi T, Toung TJ, et al. Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. Stroke. 2004;35:1180-1185.
24. Drago F, Panissidi G, Bellomio F, Dal Bello A, Aguglia E, Gorgone G. Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin Exp Pharmacol Physiol. 1985;12:107-113.
25. Isayama T, McLaughlin PJ, Zagon IS. Endogenous opioids regulate cell proliferation in the retina of developing rat. Brain Res. 1991; 544:79-85.
26. Moore TT, Potter DE. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001;73:167-178.
27. Russell KR, Potter DE. Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors. Exp Eye Res. 2002;75:259-270.
28. Stiles J, Honda CN, Krohne SG, Kazacos EA. Effect of topical administration of 1% morphine sulfate solution on signs of pain and corneal wound healing in dogs. Am J Vet Res. 2003;64:813-818.
29. Wang D, Potter DE. Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther. 1996;12:131-139.
30. Murray RB, Adler MW, Korczyn AD. The pupillary effects of opioids. Life Sci. 1983;33:495-509.
31. Russo R, Cavaliere F, Berliocchi L, et al. Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade. J Neurochem. 2008;107: 1347-1357.
32. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res. 1995;23: 121-145.
33. Howells RD, Kilpatrick DL, Bailey LC, Noe M, Udenfriend S. Proen-kephalin mRNA in rat heart. Proc Natl Acad SciUSA.1986;83: 1960-1963.
34. Salemi S, Aeschlimann A, Reisch N, et al. Detection of kappa and delta opioid receptors in skin: outside the nervous system. Bio-chem Biophys Res Commun. 2005;338:1012-1017.
35. Zagon IS, Sassani JW, Kane ER, McLaughlin PJ. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor. Brain Res. 1997;759:92-102.
36. Neely CF, Keith IM. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol. 1995;268: L1036-L1046.
37. Qiu Y, Rizvi A, Tang XL, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273:H2931-H2936.
38. Chien GL, Mohtadi K, Wolff RA, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation. Basic Res Cardiol. 1999;94: 136-143.
39. Lam TT, Takahashi K, Tso MO. The effects of naloxone on retinal ischemia in rats. J Ocul Pharmacol. 1994;10:481-492.
40. Riazi-Esfahani M, Kiumehr S, Asadi-Amoli F, Lashay AR, Dehpour AR. Morphine pretreatment provides histologic protection against ischemia-reperfusion injury in rabbit retina. Retina. 2008;28:511-517.
41. Koreh K, Seligman ML, Flamm ES, Demopoulos HB. Lipid antiox-idant properties of naloxone in vitro. Biochem Biophys Res Com-mun. 1981;102:1317-1322.
42. Medzihradsky F. Stereospecific binding of etorphine in isolated neural cells and in retina, determined by a sensitive microassay. Brain Res. 1976;108:212-219.
43. Wamsley JK, Palacios JM, Kuhar MJ. Autoradiographic localization of opioid receptors in the mammalian retina. Neurosci Lett. 1981; 27:19-24.
44. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res. 1999;84:1396-1400.
45. Zhao P, Huang Y, Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol. 2006;65:945-952.